These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1332985)

  • 1. The effect of 17 alpha-hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial.
    Prietl G; Diedrich K; van der Ven HH; Luckhaus J; Krebs D
    Hum Reprod; 1992 Jun; 7 Suppl 1():1-5. PubMed ID: 1332985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial.
    Abu-Musa A; Usta I; Nassar A; Hajami F; Hannoun A
    Fertil Steril; 2008 May; 89(5):1098-1102. PubMed ID: 17658525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17-alpha-Hydroxyprogesterone caproate and natural progesterone in assisted reproduction: a comparative study.
    Abate A; Brigandì A; Costabile L; Abate FG; Balzano E; Perino M
    Clin Exp Obstet Gynecol; 1997; 24(4):190-2. PubMed ID: 9478315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester bleeding in clinical IVF pregnancies.
    Goldman JA; Ashkenazi J; Ben-David M; Feldberg D; Dicker D; Voliovitz I
    Hum Reprod; 1988 Aug; 3(6):807-9. PubMed ID: 3220946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles.
    Costabile L; Gerli S; Manna C; Rossetti D; Di Renzo GC; Unfer V
    Fertil Steril; 2001 Aug; 76(2):394-6. PubMed ID: 11476795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer.
    Okamoto SH; Healy DL; Morrow LM; Rogers PA; Trounson AO; Wood EC
    Br Med J (Clin Res Ed); 1987 Mar; 294(6573):667-70. PubMed ID: 2436703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.
    Reijnders FJ; Thomas CM; Doesburg WH; Rolland R; Eskes TK
    Br J Obstet Gynaecol; 1988 May; 95(5):462-8. PubMed ID: 3135831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
    Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist.
    Lelaidier C; de Ziegler D; Gaetano J; Hazout A; Fernandez H; Frydman R
    Hum Reprod; 1992 Nov; 7(10):1353-6. PubMed ID: 1291558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of human diabetic pregnancies with estradiol valerate and 17 alpha-hydroxyprogesterone 17-n-caproate.
    GILLESPIE L; SEXTON LI; WHITE P
    Ann N Y Acad Sci; 1958 Jul; 71(5):794-9. PubMed ID: 13583834
    [No Abstract]   [Full Text] [Related]  

  • 13. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.
    Christian MS; Brent RL; Calda P
    J Matern Fetal Neonatal Med; 2007 Feb; 20(2):89-112. PubMed ID: 17437208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies.
    Lim AC; Schuit E; Papatsonis D; van Eyck J; Porath MM; van Oirschot CM; Hummel P; Hasaart TH; Kleiverda G; de Graaf IM; van Ginkel AA; Mol BW; Bruinse HW
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):426-30. PubMed ID: 23008102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovum donation by sisters in ovarian failure: simplified priming and early withdrawal of exogenous support.
    Rosenberg SM; East JM; Wood SC; Crain JL
    J In Vitro Fert Embryo Transf; 1989 Aug; 6(4):228-31. PubMed ID: 2515235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinology of in-vitro fertilization pregnancies during the first trimester.
    Johnson MR; Riddle AF; Grudzinskas JG; Sharma V; Campbell S; Collins WP; Lightman SL; Mason B; Nicolaides KH
    Hum Reprod; 1993 Feb; 8(2):316-22. PubMed ID: 8473440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do analogues of gonadotrophin releasing hormone influence follicular fluid steroid levels, oocyte maturity and fertilization rates?
    Tavmergen E; Tavmergen EN; Capanoğlu R
    Hum Reprod; 1992 Apr; 7(4):479-82. PubMed ID: 1387881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of early beta-human chorionic gonadotrophin values with pregnancy wastage and multiple implantation in a donor oocyte programme.
    Legro RS; Paulson RJ; Lobo RA; Sauer MV
    Hum Reprod; 1995 Dec; 10(12):3293-6. PubMed ID: 8822461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.
    Kumar D; Moore RM; Mercer BM; Mansour JM; Mesiano S; Schatz F; Lockwood CJ; Moore JJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):695.e1-695.e14. PubMed ID: 29031893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse.
    Carbone JP; Brent RL
    Am J Obstet Gynecol; 1993 Nov; 169(5):1292-8. PubMed ID: 8238197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.